Spectral Contrast Agents and Photon-counting Detectors for Spectral Computed Tomography (E!11793)

MultiContrastPhotoCT aims to generate a novel photoncounting energy‐selective CT detector technology for use in diagnostic and interventional CT. This technology enables simultaneous acquisition of up to 4 different x‐ray spectra, allowing improved visualization of various anatomical regions in a single CT scan.

A project funded by EUROSTARS, a joint programme between more than 30 Eureka member countries and the European Union.The project runs from July 2018 ‐ June 2021.

read more


The objectives of the EU‐financed NanoMag project are to standardize, improve and redefine analytical methods for magnetic nanoparticles. Using improved manufacturing technologies synthesized magnetic nanoparticles with specific properties will be analyzed using a multitude of characterization techniques (focussing on both structural and magnetic properties). Bringing the results together will provide a self‐consistent picture, describing how structural and magnetic properties are interelated.

The project has received funding from the European Union's Seventh Framework (FP7/2007-2013) under grant agreement no. 604448. The project runs from November 2013 ‐ October 2017.
read more

NanoAthero aims to demonstrate the preliminary feasibility of the use of nanosystems for targeted imaging and treatment of advanced atherothrombotic disease in humans. NanoAthero offers a unique opportunity by combining in‐depth knowledge of nanocarrier bioengineering and production with state‐of‐the‐art expertise in imaging and treatment of cardiovascular patients providing a full framework of 16 partners within one collaborative European consortium.

The project has received funding from the European Union's Seventh Framework Programme for reasearch, technological development and demonstration under grant agreement no. 309820. The project runs from February 2013 ‐ January 2018.

The IDEA project is dedicated to the development of new tools for regenerative medicine, specifically the development of new photonic methods that allow identification and selection of cells prior to transplantation. Within the project framework, devices and tracers for the homing, capturing and monitoring of such cells in vivo are developed and tested, thereby guiding therapeutic interventions of regenerative medicine through application of new imaging techniques.

IDEA is a collaborative project co‐founded under the European Commission's Seventh Framework Program – Health.2011.1.4-2 ‐ Contract no. 279288. The project runs from March 2012 ‐ February 2017.